INmune Bio
INMB
#8288
Rank
HK$1.39 B
Marketcap
HK$60.66
Share price
-2.74%
Change (1 day)
-28.51%
Change (1 year)

Revenue for INmune Bio (INMB)

Revenue in 2024 (TTM): HK$0.1 Million

According to INmune Bio's latest financial reports the company's current revenue (TTM ) is HK$0.1 Million. a decrease over the revenue in the year 2023 that were of HK$1.21 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for INmune Bio from 2018 to 2024

Annual revenue

Year Revenue Change
2024 HK$0.1 M-91.02%
2023 HK$1.21 M-58.57%
2022 HK$2.92 M107.05%
2021 HK$1.41 M1567.82%
2020 HK$0.08 M
2019 N/A
2018 N/A